Keywords: net, loss, deepens, ppl, therapeutics, remains, upbeat
Net loss deepens at PPL Therapeutics but remains upbeat about future
Article | 01 April 2002
UK biotechnology company PPL Therapeutics has posted a 150% rise inrevenues for the year ended December 31, 2001, to L2 million ($2.9 million), while ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
